Zydus Infringed AstraZeneca's Diabetes Drug IP, Judge Rules
A Delaware federal judge held Friday that Zydus Pharmaceuticals infringed an AstraZeneca patent for a diabetes drug, saying Zydus failed during a four-day bench trial to prove that any of the...To view the full article, register now.
Already a subscriber? Click here to view full article